Wiesloch, Germany

Volker Eschenfelder

This inventor holds 1 USPTO granted patent. Top assignee: Basf Aktiengesellschaft. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Volker Eschenfelder

Introduction

Volker Eschenfelder is a notable inventor based in Wiesloch, Germany. He has made significant contributions to the field of medical science, particularly in the area of thrombolytic and antithrombotic substances. His work aims to address vascular disorders caused by thrombosis, showcasing his commitment to improving healthcare outcomes.

Latest Patents

Volker Eschenfelder holds a patent for a mixture of a substance having thrombolytic activity and an antithrombotic substance. This innovative mixture is designed to control vascular disorders caused by thrombosis, highlighting the potential for new treatment options in the medical field. He has 1 patent to his name, reflecting his focused contributions to this important area of research.

Career Highlights

Eschenfelder is associated with BASF Aktiengesellschaft, a leading company in the chemical industry. His role at BASF allows him to collaborate with other experts and contribute to groundbreaking research and development projects. His work is characterized by a strong emphasis on practical applications that can benefit patients suffering from vascular disorders.

Collaborations

Some of his notable coworkers include Klaus Ruebsamen and Bernhard Schmied. Their collaboration fosters an environment of innovation and shared expertise, which is essential for advancing research in their field.

Conclusion

Volker Eschenfelder's contributions to the field of thrombolytic and antithrombotic substances demonstrate his dedication to medical innovation. His work not only highlights his inventive spirit but also underscores the importance of collaboration in achieving significant advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…